Triple-negative breast cancer (TNBC) is a highly aggressive and heterogeneous malignancy characterized by the absence of estrogen receptor (ER)and progesterone receptor (PR), and the lack of amplification/overexpression of human epidermal growth factor receptor 2 (HER2). Here, ESR1 is linked to triple-negative breast carcinoma.